News
Pierval Santé: 10 years of commitment to Paris Brain Institute
A meeting ten years ago between Jean-Jacques Olivié, President of Euryale, and Professor Gérard Saillant resulted in the first SCPI co-investment fund approved by France’s financial markets authority (AMF): Pierval Santé.
Their ambition was to combine financial performance with support for a healthier society. Through investment in care and treatment facilities (clinics, nursing homes, specialist facilities), Pierval Santé donates a portion of its funds to Paris Brain Institute each year. Investors are also invited to make a personal commitment, while Euryale makes a direct contribution as the management company.
“What sets Pierval Santé apart is our ability to create cohesion between the facility-focused investment vehicle (investments in clinical facilities, nursing homes, specialist accommodation facilities, etc.) and the research activities at Paris Brain Institute. All this while providing medical research with the ongoing and long-term funding it needs.”
Jean-Jacques Olivié
President of Euryale
This innovative model has made it possible to build sustainable and vital support for medical research, fully aligned with innovation as the central value.
Euryale, a Major Patron of Paris Brain Institute, has since redoubled its commitment through one-off donations and the launch of a new co-investment fund, SC Trajectoire Santé, with one purpose: to support researchers in their fight against neurodegenerative diseases over the long term.
